About
Dr. Roberts joined us in December 2012 and has nearly 20 years of senior technical leadership experience, most recently as Chief Scientific Officer at ImQuest BioSciences, Inc., where he was responsible for managing scientific operations as well as business development opportunities in cancer and antivirals. Dr. Roberts held key positions at Wellstat Biologics Corporation from August 1996 until October 2010, including Director of Research and Development where he was responsible for a portfolio of biologic candidates in oncology including a clinical stage asset. He also led bioassay development efforts for the company and assumed leadership roles in upstream process development and animal pharmacology while at Wellstat. Dr. Roberts has significant experience in both small molecule and biologics drug development with a focus on viral vectors and antiviral therapies. Dr. Roberts completed a post doctoral fellowship at the National Cancer Institute, Laboratory of Molecular Virology and ha
Position in the VCSift Database
- • 2 investors at Altimmune are tracked.
- • 22 investors hold the Chief Scientific Officer role in VCSift. M. Scot Roberts is one of them.
- • 1,381 investors are based in Washington, District of Columbia, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Washington, US
Contact Information
Find more investors like M. Scot
Search Investors